Global Gastrointestinal Stents Market

Gastrointestinal Stents Market Size, Share, Growth Analysis, By Products (Biliary Stents, Duodenal Stents), By Material (Self-Expanding Metal Stents, Nitinol), By Application (Biliary Diseases, Irritable Bowel Syndrome), By End Users, By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2398 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 64 | Figures: 75

Gastrointestinal Stents Market News

  • In May 2023, Boston Scientific Corporation received FDA approval for its EnterStent XR biliary stent. The EnterStent XR is a self-expandable metal stent that is designed to provide long-term relief of bile duct obstructions.
  • In April 2023, Cook Medical announced the launch of its ZilverGuard biliary stent. The ZilverGuard is a self-expandable metal stent that is coated with a proprietary antimicrobial agent to help prevent stent infections.
  • In March 2023, Medtronic plc received CE Mark for its Invatec EsophyX esophageal stent. The Invatec EsophyX is a self-expandable metal stent that is designed to provide relief of esophageal strictures.
  • In February 2023, Taewoong Medical announced the launch of its T-stent biliary stent. The T-stent is a self-expandable metal stent that is designed to provide long-term relief of bile duct obstructions.
  • In January 2023, Merit Medical Systems received FDA approval for its MULTI-STENT biliary stent. The MULTI-STENT is a self-expandable metal stent that is designed to provide relief of bile duct obstructions in patients with multiple strictures.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Gastrointestinal Stents Market size was valued at USD 5.01 Billion in 2023 and is poised to grow from USD 5.29 Billion in 2024 to USD 8.11 Billion by 2032, growing at a CAGR of 5.5% during the forecast period (2025-2032).

The global gastrointestinal stents market is highly competitive and characterized by the presence of several established and emerging players. These companies are engaged in developing and manufacturing gastrointestinal stents used in various medical applications. Gastrointestinal stents are widely utilized in the treatment of various gastrointestinal disorders and obstructions, offering a minimally invasive alternative to traditional surgical procedures. 'Boston Scientific Corporation (USA) ', 'BD (Becton, Dickinson and Company) (USA) ', 'Cook Medical (USA) ', 'Olympus Corporation (Japan) ', 'Merit Medical Systems (USA) ', 'CONMED Corporation (USA) ', 'ELLA-CS s.r.o. (Czech Republic) ', 'Hobbs Medical Inc. (USA) ', 'Taewoong Medical Co. Ltd. (South Korea) ', 'S&G Biotech Inc. (South Korea) ', 'Medtronic (Ireland) ', 'AbbVie (USA) ', 'Johnson & Johnson (USA) ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Pfizer Inc. (USA) ', 'Novartis AG (Switzerland) ', 'Bayer AG (Germany) ', 'AstraZeneca plc (UK) ', 'Roche Holding AG (Switzerland) ', 'Eli Lilly and Company (USA)'

Growing awareness among patients and healthcare providers about the benefits of gastrointestinal stents has resulted in early diagnosis and timely intervention. Furthermore, improved access to healthcare facilities in developing regions has increased the adoption of stenting procedures, propelling market expansion.

Increasing Preference for Biodegradable Stents: Biodegradable gastrointestinal stents offer several advantages over traditional metallic stents, making them an emerging and attractive option for medical practitioners and patients alike. These stents are typically made from materials that gradually dissolve over time, eliminating the need for an additional removal procedure, which is often required with permanent metallic stents. This feature reduces the risk of complications and offers a more convenient and patient-friendly treatment option. Furthermore, biodegradable stents can provide temporary support to the diseased area during the healing process, gradually losing their structural integrity as the tissue heals and regenerates.

North America emerges as the most dominant region in the global gastrointestinal stents market. The dominance of North America can be attributed to several factors. Firstly, the region has a well-established healthcare infrastructure and a high level of awareness about advanced medical treatments. Secondly, there is a substantial patient pool suffering from gastrointestinal disorders, including colorectal cancer, esophageal cancer, and benign strictures.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Stents Market
Buy Now GET FREE SAMPLE
Coronary Stent Market
Buy Now GET FREE SAMPLE
Branched Stent Grafts Market
Buy Now GET FREE SAMPLE
Cerebral Vascular Stent Market
Buy Now GET FREE SAMPLE
Aortic Stent Grafts Market
Buy Now GET FREE SAMPLE
Steviol Glycoside Market
Buy Now GET FREE SAMPLE
Peptic Ulcer Drugs Market
Buy Now GET FREE SAMPLE
Stethoscope Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Gastrointestinal Stents Market

Report ID: SQMIG35A2398

$5,300
BUY NOW GET FREE SAMPLE